Loai Aker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Loai Aker has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Hassan El Beltagi
From the Department of Radiology, Neuroradiology Section, University of Arkansas for Medical Sciences, Little Rock, Ark (S.V.); Department of Clinical Imaging, Hamad General Hospital (L.A.), and Department of Neuroradiology, Neuroscience Institute (M.A., A.H.E.B.), Hamad Medical, PO Box 3050, Alsadd, Doha, Qatar; and Department of Clinical Radiology, Weill Cornell Medicine, Doha, Qatar (A.H.E.B.).
4 shared publications - Surjith Vattoth
From the Department of Radiology, Neuroradiology Section, University of Arkansas for Medical Sciences, Little Rock, Ark (S.V.); Department of Clinical Imaging, Hamad General Hospital (L.A.), and Department of Neuroradiology, Neuroscience Institute (M.A., A.H.E.B.), Hamad Medical, PO Box 3050, Alsadd, Doha, Qatar; and Department of Clinical Radiology, Weill Cornell Medicine, Doha, Qatar (A.H.E.B.).
4 shared publications - Mohamed Abdelhady
From the Department of Radiology, Neuroradiology Section, University of Arkansas for Medical Sciences, Little Rock, Ark (S.V.); Department of Clinical Imaging, Hamad General Hospital (L.A.), and Department of Neuroradiology, Neuroscience Institute (M.A., A.H.E.B.), Hamad Medical, PO Box 3050, Alsadd, Doha, Qatar; and Department of Clinical Radiology, Weill Cornell Medicine, Doha, Qatar (A.H.E.B.).
3 shared publications - Hassan Aboughalia
Children's National Medical Center, Department of Radiology, USA
2 shared publications Laith Abandeh
Department of Radiology, University of Washington, Seattle, WA, USA
2 shared publicationsMohamed Abdelhady
Neuroradiology Section, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar
2 shared publications
Latest Publications
- 16 October 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
Prognostic significance of contrast enhancement in newly diagnosed grade 2 IDH-mutant glioma
Background: Contrast enhancement is generally considered an adverse prognostic feature in adult glioma. However, its significance in newly diagnosed grade 2 isocitrate dehydrogenase (IDH)-mutant glioma remains uncertain, with important implications for use of the mutant IDH inhibitor vorasidenib. We evaluated survival outcomes associated with preoperative enhancement in this population. Methods: We retrospectively evaluated consecutive patients with grade 2 IDH-mutant glioma treated at 2 institutions between 2010 and 2021. Preoperative MRIs were assessed for intratumoral enhancement by 2 independent readers with third-reader adjudication. Overall survival (OS) and progression-free survival (PFS) were evaluated by Kaplan-Meier analysis and univariate and multivariable Cox regression. Results: Among 325 evaluable patients, the median age was 37 years, 47% had 1p/19q-codeletion, and 35% had gross total resection. Median follow-up was 10.5 years. Preoperative enhancement was observed in 53 (16%) patients, most commonly nonmeasurable (72%) or ill-defined (62%); most (87%) had no residual postoperative enhancement. Preoperative enhancement was not associated with OS or PFS in either univariate analyses (OS hazard ratio [HR] 1.16 [0.67-2.01], P = .591; PFS HR 1.25 [0.88-1.80], P = .216) or multivariable analyses adjusting for established prognostic factors (OS HR 0.86 [0.46-1.61], P = .633; PFS HR 1.29 [0.86-1.92], P = .219). Enhancement characteristics (measurable size, well-defined morphology) were not associated with OS. Conclusions: In grade 2 IDH-mutant glioma, preoperative enhancement was not associated with OS or PFS. These findings suggest that preoperative enhancement does not identify a higher-risk subgroup in this population and that its presence alone should not preclude consideration of vorasidenib in eligible patients.
- 16 October 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
Prognostic significance of contrast enhancement in newly diagnosed grade 2 IDH-mutant glioma
Background: Contrast enhancement is generally considered an adverse prognostic feature in adult glioma. However, its significance in newly diagnosed grade 2 isocitrate dehydrogenase (IDH)-mutant glioma remains uncertain, with important implications for use of the mutant IDH inhibitor vorasidenib. We evaluated survival outcomes associated with preoperative enhancement in this population. Methods: We retrospectively evaluated consecutive patients with grade 2 IDH-mutant glioma treated at 2 institutions between 2010 and 2021. Preoperative MRIs were assessed for intratumoral enhancement by 2 independent readers with third-reader adjudication. Overall survival (OS) and progression-free survival (PFS) were evaluated by Kaplan-Meier analysis and univariate and multivariable Cox regression. Results: Among 325 evaluable patients, the median age was 37 years, 47% had 1p/19q-codeletion, and 35% had gross total resection. Median follow-up was 10.5 years. Preoperative enhancement was observed in 53 (16%) patients, most commonly nonmeasurable (72%) or ill-defined (62%); most (87%) had no residual postoperative enhancement. Preoperative enhancement was not associated with OS or PFS in either univariate analyses (OS hazard ratio [HR] 1.16 [0.67-2.01], P = .591; PFS HR 1.25 [0.88-1.80], P = .216) or multivariable analyses adjusting for established prognostic factors (OS HR 0.86 [0.46-1.61], P = .633; PFS HR 1.29 [0.86-1.92], P = .219). Enhancement characteristics (measurable size, well-defined morphology) were not associated with OS. Conclusions: In grade 2 IDH-mutant glioma, preoperative enhancement was not associated with OS or PFS. These findings suggest that preoperative enhancement does not identify a higher-risk subgroup in this population and that its presence alone should not preclude consideration of vorasidenib in eligible patients.
- Open Access
- 6 August 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (8) , e7743
Injury to the circuit of Papez: An overlooked cause of recurrent seizures
Key Clinical Message: Papez' circuit is a unique neural pathway in the limbic system that is correlated with seizure activity. Injuries affecting Papez' circuit are often small and unusual in location but can be identifiable in MRI and functional imaging modalities, which can be helpful in the workup of refractory epilepsy. The Papez circuit is a unique neural pathway in the limbic system of the brain. We review a patient presenting with recurrent seizures as the main manifestation of Papez' circuit pathology. The radiologic features of ischemia involving the mammillothalamic tract in Papez' circuit were correlated with the seizure activity.
- 6 August 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (8) , e7743
Open AccessInjury to the circuit of Papez: An overlooked cause of recurrent seizures
Key Clinical Message: Papez' circuit is a unique neural pathway in the limbic system that is correlated with seizure activity. Injuries affecting Papez' circuit are often small and unusual in location but can be identifiable in MRI and functional imaging modalities, which can be helpful in the workup of refractory epilepsy. The Papez circuit is a unique neural pathway in the limbic system of the brain. We review a patient presenting with recurrent seizures as the main manifestation of Papez' circuit pathology. The radiologic features of ischemia involving the mammillothalamic tract in Papez' circuit were correlated with the seizure activity.
- Open Access
- 4 August 2023
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (10) , 3642-3647
Imaging features of fulminant cerebral malaria: A case report
- 4 August 2023
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (10) , 3642-3647
Open AccessImaging features of fulminant cerebral malaria: A case report
- 1 February 2023
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 5 (2)
Postradiation Therapy Changes of the Superior Cervical Ganglion
- 1 February 2023
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 5 (2)
Postradiation Therapy Changes of the Superior Cervical Ganglion
- Open Access
- 11 September 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (11) , 4264-4267
Optic cupping secondary to periventricular leukomalacia: A potential mimic for normal pressure glaucoma
- 11 September 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (11) , 4264-4267
Open AccessOptic cupping secondary to periventricular leukomalacia: A potential mimic for normal pressure glaucoma
- Open Access
- 1 July 2022
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 51 (4) , 568-578
Susceptibility-weighted Imaging in Neuroradiology: Practical Imaging Principles, Pearls and Pitfalls
- 1 July 2022
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 51 (4) , 568-578
Open AccessSusceptibility-weighted Imaging in Neuroradiology: Practical Imaging Principles, Pearls and Pitfalls
- 1 June 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , 726-730
Case 302: Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids
History Part one of this case appeared 4 months previously and may contain larger images. A 21-year-old immunocompetent man who was a long-term resident of Qatar presented to the emergency departme...
- 1 June 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , 726-730
Case 302: Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids
History Part one of this case appeared 4 months previously and may contain larger images. A 21-year-old immunocompetent man who was a long-term resident of Qatar presented to the emergency departme...
- 1 April 2022
- Published by Elsevier in Foot and Ankle Surgery
- Vol. 28 (3) , 338-346
Magnetic resonance imaging of severe idiopathic club foot treated with one-week accelerated Ponseti (OWAP) technique
- 1 April 2022
- Published by Elsevier in Foot and Ankle Surgery
- Vol. 28 (3) , 338-346
Magnetic resonance imaging of severe idiopathic club foot treated with one-week accelerated Ponseti (OWAP) technique
- 1 January 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 302 (2) , 481-483
Case 302
History A 21-year-old immunocompetent man who was a long-term resident of Qatar presented to the emergency department with recurrent episodes of unprovoked generalized tonic-clonic seizures lasting 2–3 minutes that spontaneously resolved and were associated with postictal confusion. The patient also had progressive mild diplopia, intermittent dizziness, and numbness in the left arm over the course of 3 months. The patient did not have any other systemic symptoms or chronic medical diseases. He did not have any history of intake of illicit drugs, supplements, or regular medications; he had not received any recent vaccinations; and he had not undergone any surgical procedures. He had no history of travel. At presentation, vital signs were normal. Neurologic examination showed mild left homonymous hemianopia, normal gait with no cerebellar signs, and preserved sensations, power, tone, and reflexes in all four limbs. An electroencephalogram showed no epileptiform discharges. Chest CT and extensive laboratory work-up, including viral, fungal, bacterial, and parasite work-up, thyroid function tests, and immunologic blood tests yielded normal results. Those included normal complete and differential blood counts and normal serum chemistry. Serum analysis was negative for antinuclear antibody, Sjögren syndrome antigens A and B, cytoplasmic antineutrophil cvtoplasmic antibody, and paraneoplastic profile. Serum evaluation was also negative for human immunodeficiency virus type 1 and type 2 RNA, and Brucella, Schistosoma, and toxoplasma antibodies. Venereal Disease Research Laboratory (VDRL) and rapid plasma regain (RPR) test results were negative. Cerebrospinal fluid (CSF) analysis revealed clear fluid and normal pressure and biochemistry, except for elevated protein concentration (0.48 g/L) (normal range, 0.15–0.45 g/L). There were 43 leukocytes/µL (99% lymphocytes) (normal range, 0–5 leukocytes/µL; lymphocytes range, 40%–80%), with no atypical or malignant cells. CSF Gram staining, acid-fast staining, cryptococcal antigen, varicella-zoster virus polymerase chain reaction (PCR), herpes simplex virus PCR, VDRL, and RPR test results were negative. CSF cultures did not show any evidence of growth of bacteria, fungi, or acid-fast bacillus. CSF flow cytometry did not show a monoclonal lymphoid population. No CSF oligoclonal bands were detected. Conventional brain MRI with intravenous administration of contrast material and a perfusion study were performed and included different sequences (Figs 1–3).
- 1 January 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 302 (2) , 481-483
Case 302
History A 21-year-old immunocompetent man who was a long-term resident of Qatar presented to the emergency department with recurrent episodes of unprovoked generalized tonic-clonic seizures lasting 2–3 minutes that spontaneously resolved and were associated with postictal confusion. The patient also had progressive mild diplopia, intermittent dizziness, and numbness in the left arm over the course of 3 months. The patient did not have any other systemic symptoms or chronic medical diseases. He did not have any history of intake of illicit drugs, supplements, or regular medications; he had not received any recent vaccinations; and he had not undergone any surgical procedures. He had no history of travel. At presentation, vital signs were normal. Neurologic examination showed mild left homonymous hemianopia, normal gait with no cerebellar signs, and preserved sensations, power, tone, and reflexes in all four limbs. An electroencephalogram showed no epileptiform discharges. Chest CT and extensive laboratory work-up, including viral, fungal, bacterial, and parasite work-up, thyroid function tests, and immunologic blood tests yielded normal results. Those included normal complete and differential blood counts and normal serum chemistry. Serum analysis was negative for antinuclear antibody, Sjögren syndrome antigens A and B, cytoplasmic antineutrophil cvtoplasmic antibody, and paraneoplastic profile. Serum evaluation was also negative for human immunodeficiency virus type 1 and type 2 RNA, and Brucella, Schistosoma, and toxoplasma antibodies. Venereal Disease Research Laboratory (VDRL) and rapid plasma regain (RPR) test results were negative. Cerebrospinal fluid (CSF) analysis revealed clear fluid and normal pressure and biochemistry, except for elevated protein concentration (0.48 g/L) (normal range, 0.15–0.45 g/L). There were 43 leukocytes/µL (99% lymphocytes) (normal range, 0–5 leukocytes/µL; lymphocytes range, 40%–80%), with no atypical or malignant cells. CSF Gram staining, acid-fast staining, cryptococcal antigen, varicella-zoster virus polymerase chain reaction (PCR), herpes simplex virus PCR, VDRL, and RPR test results were negative. CSF cultures did not show any evidence of growth of bacteria, fungi, or acid-fast bacillus. CSF flow cytometry did not show a monoclonal lymphoid population. No CSF oligoclonal bands were detected. Conventional brain MRI with intravenous administration of contrast material and a perfusion study were performed and included different sequences (Figs 1–3).
- Open Access
- 1 September 2021
- Published by Elsevier in Radiology Case Reports
- Vol. 16 (9) , 2812-2816
Metastatic angiosarcoma of the scalp presented as posttraumatic subgaleal hematoma: The many faces of a diagnostic challenge
- 1 September 2021
- Published by Elsevier in Radiology Case Reports
- Vol. 16 (9) , 2812-2816
Open AccessMetastatic angiosarcoma of the scalp presented as posttraumatic subgaleal hematoma: The many faces of a diagnostic challenge